SITC’s Guide to Managing Immunotherapy Toxicity

SITC’s Guide to Managing Immunotherapy Toxicity PDF Author: Marc S. Ernstoff, MD
Publisher: Springer Publishing Company
ISBN: 0826172156
Category : Medical
Languages : en
Pages : 275

Get Book Here

Book Description
The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers. With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care. Key Features: Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy Provides numerous tables that condense and highlight pertinent information for quick reference Describes the various clinical presentations and toxic reactions caused by immunotherapy Purchase includes access to the eBook for use on most mobile devices or computer

SITC’s Guide to Managing Immunotherapy Toxicity

SITC’s Guide to Managing Immunotherapy Toxicity PDF Author: Marc S. Ernstoff, MD
Publisher: Springer Publishing Company
ISBN: 0826172156
Category : Medical
Languages : en
Pages : 275

Get Book Here

Book Description
The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers. With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care. Key Features: Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy Provides numerous tables that condense and highlight pertinent information for quick reference Describes the various clinical presentations and toxic reactions caused by immunotherapy Purchase includes access to the eBook for use on most mobile devices or computer

NCCN Guidelines for Patients® Immunotherapy Side Effects - Immune Checkpoint Inhibitors

NCCN Guidelines for Patients® Immunotherapy Side Effects - Immune Checkpoint Inhibitors PDF Author: National Comprehensive Cancer Network® (NCCN®)
Publisher:
ISBN: 9781945835933
Category :
Languages : en
Pages :

Get Book Here

Book Description
[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network® (NCCN®) comes this essential guide to Immunotherapy Side Effects - Immune Checkpoint Inhibitors. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: checkpoint inhibitors and immune-related adverse events (irAEs), skin irAEs, fatigue, gastrointestinal irAEs, endocrine irAEs, lung irAEs, musculoskeletal irAEs, less common irAEs, and resources. Let this authoritative handbook be your guide!

Stereotactic Body Radiation Therapy

Stereotactic Body Radiation Therapy PDF Author: Simon S. Lo
Publisher: Springer Science & Business Media
ISBN: 364225604X
Category : Medical
Languages : en
Pages : 433

Get Book Here

Book Description
Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists.

Cancer Vaccines and Immunotherapy

Cancer Vaccines and Immunotherapy PDF Author: Peter L. Stern
Publisher: Cambridge University Press
ISBN: 9780521622639
Category : Medical
Languages : en
Pages : 304

Get Book Here

Book Description
Rapid progress in the definition of tumor antigens, and improved immunization methods, bring effective cancer vaccines within reach. In this wide-ranging survey, leading clinicians and scientists review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, their contributions cover the rationale, development, and implementation of vaccines in human cancer treatment, with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. They review target identification, delivery vectors and clinical trial design. The book begins and ends with lucid overviews from the editors, that discuss the most recent developments.

Upper Tract Urothelial Carcinoma

Upper Tract Urothelial Carcinoma PDF Author: Shahrokh F. Shariat
Publisher: Springer
ISBN: 1493915010
Category : Medical
Languages : en
Pages : 206

Get Book Here

Book Description
Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.

NCCN Guidelines for Patients® Non-Small Cell Lung Cancer Early and Locally Advanced

NCCN Guidelines for Patients® Non-Small Cell Lung Cancer Early and Locally Advanced PDF Author: National Comprehensive Cancer Network® (NCCN®)
Publisher:
ISBN: 9781954190672
Category :
Languages : es
Pages : 0

Get Book Here

Book Description
[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Efectos secundarios de la inmunoterapia Inhibidores del punto de control inmunitario. Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include:Efectos secundarios de la inmunoterapia: aspectos básicos, Piel, Fatiga, Intestino e hígado, Hormonas, Pulmones, Músculos y articulaciones, Efectos secundarios menos comunes, Recursos, Palabras que debe saber, Colaboradores de NCCN, Centros oncológicos de NCCN, Índice.

Diagnosing and Treating Adult Cancers and Associated Impairments

Diagnosing and Treating Adult Cancers and Associated Impairments PDF Author: National Academies Of Sciences Engineeri
Publisher: National Academies Press
ISBN: 9780309684002
Category : Medical
Languages : en
Pages :

Get Book Here

Book Description
Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer.

NCCN Guidelines for Patients® Bone Cancer

NCCN Guidelines for Patients® Bone Cancer PDF Author: National Comprehensive Cancer Network® (NCCN®)
Publisher:
ISBN: 9781954190771
Category :
Languages : en
Pages : 0

Get Book Here

Book Description
[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Bone Cancer. Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: Bone cancer basics,Testing for bone cancer, Cancer staging, Treatment overview, Chondrosarcoma, Chordoma, Ewing sarcoma, Giant cell tumor of bone, Osteosarcoma, Making treatment decisions, Words to know, NCCN Contributors, NCCN Cancer Centers, Index.

Immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer and esophageal cancer

Immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer and esophageal cancer PDF Author: Xuelei Ma
Publisher: Frontiers Media SA
ISBN: 2832509150
Category : Medical
Languages : en
Pages : 537

Get Book Here

Book Description


Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitors PDF Author: Afsheen Raza
Publisher: BoD – Books on Demand
ISBN: 180356590X
Category : Medical
Languages : en
Pages : 214

Get Book Here

Book Description
Immune Checkpoint Inhibitors - New Insights and Recent Progress explores a vast array of subjects related to immune checkpoint inhibitors and presents novel insights in this emerging field. Chapters address such topics as mechanistic approaches of emerging immune checkpoint inhibitors, their role in clinical and pre-clinical trials, the manipulation of the system by immune-related adverse events that hinder the utility of these immune molecules, and the predictive and prognostic aspects of these molecules as biomarkers of response in immunotherapy. The book is useful for students, clinicians, and scientists to gain updated information on managing patients treated with immune checkpoint inhibitors.